Brii Biosciences Limited (HKG:2137)
Hong Kong
· Delayed Price · Currency is HKD 2.090
+0.140 (7.18%)
May 2, 2025, 4:08 PM HKT
Brii Biosciences Revenue
In the year 2024, Brii Biosciences had annual revenue of 54.99M CNY, down -2.36%. Brii Biosciences had revenue of 32.84M in the half year ending December 31, 2024, a decrease of -65.21%.
Revenue
54.99M CNY
Revenue Growth
-2.36%
P/S Ratio
25.68
Revenue / Employee
561.13K CNY
Employees
98
Market Cap
1.50B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |